References

• 2007Neoliberal Economists and Capital Account Liberalization in Emerging Markets305 cited
• 2004The Activist State277 cited
• 1983The Pharmaceutical Industry and Dependency in the Third World257 cited
• 2005The WTO Medicines Decision: World Pharmaceutical Trade and the Protection of Public Health193 cited
• 2004How Do Patents And Economic Policies Affect Access To Essential Medicines In Developing Countries?184 cited
• 2001Do Patents for Antiretroviral Drugs Constrain Access to AIDS Treatment in Africa?169 cited
• 2007When Does Diffusion Matter? Explaining the Spread of Structural Pension Reforms Across Nations166 cited
• 2005The WTO and India's Pharmaceuticals Industry: Patent Protection, TRIPS, and Developing Countries161 cited
• 2002Political Bias in Policy Convergence: Privatization Choices in Latin America142 cited
• 2007Evolution of Antiretroviral Drug Costs in Brazil in the Context of Free and Universal Access to AIDS Treatment142 cited
• 2004WTO DECISION ON IMPLEMENTATION OF PARAGRAPH 6 OF THE DOHA DECLARATION ON THE TRIPS AGREEMENT AND PUBLIC HEALTH: A SOLUTION TO THE ACCESS TO ESSENTIAL MEDICINES PROBLEM?127 cited
• 2000Integrating public health concerns into patent legislation in developing countries120 cited
• 1993SOCIAL COSTS AND BENEFITS OF INTRODUCING PATENT PROTECTION FOR PHARMACEUTICAL DRUGS IN DEVELOPING COUNTRIES105 cited